MDLN
Medline Inc.Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- May 28 ▼ 3 insiders sell $3.5B at $36.54
- Jun 1 ▼ Two 10% owners (Blackstone-affiliated entities) sold a combined 39.4…
- Jun 1 ▼ Two 10% owners of Medline Inc. sold a combined 39.4M shares in open-…
- Jun 16 ▼ 1 insider sell $3.7M at $36.77
- Jun 30 ▲ 10 funds open new positions (13F)
- Aug 5 to Aug 14 ▼ 5 days of insider sells: $158.3M by 1 insider, avg $35.65
- Aug 5 Medline reported Q2 2026 adjusted EPS of $0.50, beating consensus of…
- Sep 30 ▼ Short interest jumps 27.5% to 52.69M
- Oct 2 to Oct 8 ▼ 4 days of insider sells: $996.4M by 1 insider, avg $34.97
- Oct 21 ▼ Medline initiated a voluntary field action to remove and discontinue…
- Nov 4 ▲ Medline reported Q3 2026 net sales of $7.9B (+10.4% YoY) and adjuste…
- Nov 4 ▲ Earnings: MDLN Q3 2026 Earnings: EPS $0.44 (+23.9% vs est)
- Nov 16 New catalyst: subscribers see the details Unlock
Signal stack
Where each data set points today.
- InsidersBEARISH
5 insiders sold $4.7B.
- InstitutionsBULLISH
Q2 2026: 82 added (10 new), 34 trimmed or exited. Largest new: Robeco Institutional Asset Management B.V $64.2M, Worldquant Millennium Advisors $42.7M.
- AnalystsBULLISH
27 of 34 rate it Buy or better. Median target $46.00 (+17%).
- Short sellersSTEADY
Short interest −7.3% to 37.84M shares. 3.8 days to cover, ≈2.9% of shares.
- TrendUPTREND
11% above its 50-day average.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| FMR LLC | ADD | $1.9B |
| Capital Research Global Investors | ADD | $1.6B |
| BlackRock, Inc. | ADD | $1.0B |
| MORGAN STANLEY | ADD | $852.1M |
| LONE PINE CAPITAL LLC | ADD | $827.0M |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | ADD | $787.1M |
| Egerton Capital (UK) LLP | DOUBLED | $649.6M |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | DOUBLED | $471.6M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
34 analystsPrice is inside the target range. Median implies +17%.Targets as of Nov 16, 2026.
| Date | Firm | Rating |
|---|---|---|
| Nov 5, 2026 | UBS MAINTAIN | Buy |
| Nov 5, 2026 | Citigroup MAINTAIN | Buy |
| Nov 5, 2026 | Leerink Partners MAINTAIN | Outperform |
| Nov 5, 2026 | Evercore ISI Group MAINTAIN | Outperform |
| Nov 5, 2026 | BTIG REITERATE | Buy |
| Oct 22, 2026 | Mizuho MAINTAIN | Outperform |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
GIC Private Ltd 10%+ Owner Oct 8, 2026 | SELL | $274.8M |
GIC Private Ltd 10%+ Owner Oct 6, 2026 | SELL | $73.2M |
GIC Private Ltd 10%+ Owner Oct 6, 2026 | SELL | $251.8M |
GIC Private Ltd 10%+ Owner Oct 5, 2026 | SELL | $60.4M |
GIC Private Ltd 10%+ Owner Oct 2, 2026 | SELL | $245.4M |
GIC Private Ltd 10%+ Owner Oct 2, 2026 | SELL | $90.9M |
Boyle James M Chief Executive Officer Aug 19, 2026 | AWARD | 764,252 sh |
Miller Stephen L Chief Operating Officer Aug 19, 2026 | AWARD | 87,667 sh |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Washington
Short side
FINRA· Oct 30, 2026SecBot reports
25 filings · 5 press releases · 1 bullish · 5 bearish · 4 mixed · 15 neutral- BEARISH PRESS RELEASENov 16, 2026
Selling stockholders affiliated with Blackstone, Carlyle, Hellman & Friedman, GIC, and ADIA are offering 60 million shares of Medline Class A common stock in an underwritten public offering, with an option for an additional 9 million shares. Medline will not receive any proceeds, but it and…
🔒 Fresh report (last 24h), subscribers only
- NEUTRAL S-1Nov 16, 2026
Medline Inc., the largest provider of medical-surgical products and supply chain solutions, filed an S-1 for a secondary offering of 60 million shares of Class A common stock by selling stockholders, with a concurrent $200 million repurchase of shares and units. The company reported net sales of…
🔒 Fresh report (last 24h), subscribers only
- NEUTRAL SC 13GNov 13, 2026
Capital Research Global Investors filed a Schedule 13G disclosing a 5.4% passive stake in Medline…
Monitor for any future 13D conversion by CRGI or other large holders, though the passive certification makes this unlikely. The combined disclosed passive ownership (CRGI 5.4% + GIC 8.49%) exceeds…
- NEUTRAL 144Nov 13, 2026
Stephen L. Miller, an officer of Medline Inc., filed a Form 144 notice of intent to sell 39,819…
The proposed sale is small relative to the company's market cap and the insider's likely total holdings. Monitor for actual sale completion via Form 4 filings, but this filing alone does not signal…
All MDLN filing & press-release reports (30)
- PRESS-RELEASE reportNov 16, 2026
- S-1 reportNov 16, 2026
- SC 13G reportNov 13, 2026
- 144 reportNov 13, 2026
- SC 13G/A reportNov 6, 2026
- 8-K reportNov 4, 2026
- PRESS-RELEASE reportNov 4, 2026
- INST-CLUSTER reportNov 2, 2026
- SC 13G/A reportOct 30, 2026
- 8-K reportOct 21, 2026
- 8-K reportOct 15, 2026
- PRESS-RELEASE reportOct 6, 2026
- PRESS-RELEASE reportAug 5, 2026
- 8-K reportAug 5, 2026
- 8-K reportJul 9, 2026
- INST-CLUSTER reportJun 11, 2026
- 8-K reportJun 2, 2026
- CLUSTER reportJun 1, 2026
- CLUSTER reportJun 1, 2026
- EFFECT reportMay 22, 2026
- PRESS-RELEASE reportMay 21, 2026
- PRESS-RELEASE reportMay 20, 2026
- 8-K reportMay 6, 2026
- PRESS-RELEASE reportMay 6, 2026
- DEFA14A reportApr 23, 2026
- 424B4 reportMar 6, 2026
- PRESS-RELEASE reportMar 4, 2026
- PRESS-RELEASE reportMar 3, 2026
- S-1 reportMar 3, 2026
- 8-K reportFeb 25, 2026